Two Sigma Advisers LP reduced its stake in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 45.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 74,400 shares of the company's stock after selling 63,100 shares during the quarter. Two Sigma Advisers LP owned 0.18% of Varex Imaging worth $1,085,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Wealthfront Advisers LLC acquired a new position in shares of Varex Imaging during the fourth quarter worth about $18,900,000. Royce & Associates LP increased its position in shares of Varex Imaging by 70.4% during the fourth quarter. Royce & Associates LP now owns 746,770 shares of the company's stock worth $10,895,000 after acquiring an additional 308,629 shares during the last quarter. Boston Partners bought a new stake in shares of Varex Imaging in the 4th quarter valued at approximately $8,718,000. AQR Capital Management LLC boosted its position in Varex Imaging by 18.0% during the 4th quarter. AQR Capital Management LLC now owns 570,876 shares of the company's stock valued at $8,329,000 after purchasing an additional 87,098 shares during the period. Finally, Russell Investments Group Ltd. raised its stake in Varex Imaging by 510.7% during the 4th quarter. Russell Investments Group Ltd. now owns 471,612 shares of the company's stock valued at $6,881,000 after acquiring an additional 394,381 shares in the last quarter.
Varex Imaging Stock Up 4.4%
NASDAQ:VREX traded up $0.35 during trading hours on Wednesday, reaching $8.26. The company had a trading volume of 316,777 shares, compared to its average volume of 580,252. Varex Imaging Co. has a twelve month low of $6.76 and a twelve month high of $16.93. The firm has a market cap of $340.31 million, a price-to-earnings ratio of -7.06 and a beta of 0.62. The business's 50-day simple moving average is $8.15 and its two-hundred day simple moving average is $11.99. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02.
Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. The firm had revenue of $212.90 million during the quarter, compared to analyst estimates of $206.76 million. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. The business's revenue for the quarter was up 3.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.16 EPS. On average, equities analysts expect that Varex Imaging Co. will post 0.53 earnings per share for the current year.
Wall Street Analyst Weigh In
Several brokerages recently commented on VREX. Oppenheimer reduced their price target on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research report on Friday, February 7th. B. Riley raised shares of Varex Imaging to a "strong-buy" rating in a report on Monday, May 12th. Finally, Wall Street Zen lowered shares of Varex Imaging from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd.
Get Our Latest Report on Varex Imaging
Insider Activity
In other Varex Imaging news, SVP Kimberley E. Honeysett sold 4,007 shares of the stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total transaction of $51,329.67. Following the sale, the senior vice president now owns 4,002 shares of the company's stock, valued at approximately $51,265.62. This trade represents a 50.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total transaction of $98,338.76. Following the completion of the transaction, the chief executive officer now owns 190,193 shares in the company, valued at approximately $2,137,769.32. This trade represents a 4.40% decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.
About Varex Imaging
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Recommended Stories

Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.